Literature DB >> 15650385

Limb lymph node response to bone fracture.

Grzegorz Szczesny1, Waldemar L Olszewski, Marzanna Zaleska.   

Abstract

In previous clinical studies, dilation of afferent lymphatics and enlargement of inguinal lymph nodes (LN) were observed in lymphoscintigrams from patients with persistent posttraumatic edema of lower extremities after fractures and trauma of soft tissues. In this study, changes in rat popliteal and iliac lymph nodes draining lymph from the site of tibial fracture and adjacent soft tissue injury were investigated. The observed parameters were lymph node weight, cell number, phenotype frequency, cell cytokine expression, and reactivity to mitogens. The key observations included: a) increase in the weight and total cell number of the lymph nodes; b) increased autotransformation rate and responsiveness of lymph node cells to mitogen; c) decreased frequency of ED1 macrophages and activated OX8 cytotoxic cells in flow cytometry analysis; d) high expression of OX6 class II-positive, OX7 (stem cells), OX62 (migrating dendritic cells), ED1 (macrophages), and OX12 (B cells) on immunohistochemical sections of LNs with some few HIS48 (granulocytes); e) high expression of NOS3 and TGF beta by lymph node lymphocytes and endothelial cells. In summary, local lymph nodes reacted to internal wounds, such as bone fracture and injury to adjacent tissues, through mobilization of cells from the blood circulation, along with activation of cellular subsets. The molecular mechanism that provides the signal for this reaction remains unknown. The absence of major changes in the frequency of lymph node cell subpopulations indicates that lymph nodes are constitutively prepared for influx of antigens from damaged tissues and react only with increase in cell number and cell activation. The nature of the reaction, including lack of immunization against autoantigens, remains unclear. Further elucidation will require studies on the mechanism of cross-tolerance to self-antigens during wound healing.

Entities:  

Mesh:

Year:  2004        PMID: 15650385     DOI: 10.1089/lrb.2004.2.155

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  7 in total

1.  An integrated therapy concept for reduction of postoperative complications after resection of a panniculus morbidus.

Authors:  Georgios Koulaxouzidis; Sebastian M Goerke; Steffen U Eisenhardt; Florian Lampert; G Bjoern Stark; Etelka Foeldi; Nestor Torio-Padron
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

2.  Towards Understanding the Lymph Node Response to Skin Infection with Saprophytic Staphylococcus epidermidis.

Authors:  Marta Cąkała-Jakimowicz; Monika Puzianowska-Kuznicka
Journal:  Biomedicines       Date:  2022-04-28

3.  IL-6 signaling mediates the germinal center response, IgM production and nociceptive sensitization in male mice after tibia fracture.

Authors:  Wen-Wu Li; Yang Yang; Tian-Zhi Guo; Peyman Sahbaie; Xiao-You Shi; Qin Guang; Wade S Kingery; Leonore A Herzenberg; J David Clark
Journal:  Brain Behav Immun       Date:  2021-02-23       Impact factor: 7.217

4.  Chronic lower limb wounds evoke systemic response of the lymphatic (immune) system.

Authors:  W L Olszewski; P Jain; M Zaleska; E Stelmach; E Swoboda
Journal:  Indian J Plast Surg       Date:  2012-05

5.  Identification of key gene networks associated with fracture healing using αSMA‑labeled progenitor cells.

Authors:  Hua Wang; Yongxiang Wang; Jinshan He; Chunyu Diao; Junying Sun; Jingcheng Wang
Journal:  Mol Med Rep       Date:  2018-05-17       Impact factor: 2.952

6.  Bone development and fracture healing is normal in mice that have a defect in the development of the lymphatic system.

Authors:  A L McCarter; A Khalid; J J Rios; M T Dellinger; Y Yi; M Monroy; H Zhao
Journal:  Lymphology       Date:  2020       Impact factor: 1.286

7.  Neuropeptide regulation of adaptive immunity in the tibia fracture model of complex regional pain syndrome.

Authors:  Wen-Wu Li; Tian-Zhi Guo; Xiaoyou Shi; Frank Birklein; Tanja Schlereth; Wade S Kingery; J David Clark
Journal:  J Neuroinflammation       Date:  2018-04-11       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.